Evaluation of anticancer activity of 4-vinyl-1-arylsulfonylimidazolidinones

Arch Pharm Res. 2006 Sep;29(9):721-7. doi: 10.1007/BF02974070.

Abstract

To continue exploration of structure activity relationship of novel 1-(indoline-5-sulfonyl)-4-phenylimidazolidinones (1) reported as anticancer agent with broad spectrum, three 1-(arylsulfonyl)-4-vinylimidazolidinones (2) were synthesized from methyl serinate (3) in 8 steps. Reaction of intermediate 2-phenoxycarbonylaminobut-3-enyl p-toluenesulfonate (10) with arylsulfonamide in the presence of potassium carbonate produced corresponding 2 and N-(4-vinyloxazolidin-2-yl)arylsulfonamide 11 in approximately equal ratio. This reaction is believed to undergo through urea intermediate 16 as shown in scheme 3. 1-Arylsufonyl-4-vinylimidazolidinones 2 show much reduced activity against human colon carcinoma (Colo205), human chronic myelogenous leukemia (K562), and human ovarian adenocarcinoma (SK-OV-3) and compatible activity against human lung carcinoma (A549) compared to 1. Therefore phenyl at 4-position should be the optimum planar motif for the activity of 1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / chemical synthesis*
  • Antineoplastic Agents / pharmacology*
  • Drug Screening Assays, Antitumor
  • Humans
  • Hydantoins / chemical synthesis*
  • Hydantoins / pharmacology*
  • Spectrophotometry, Ultraviolet
  • Structure-Activity Relationship
  • Tetrazolium Salts
  • Thiazoles
  • Vinyl Compounds / chemical synthesis*
  • Vinyl Compounds / pharmacology*

Substances

  • Antineoplastic Agents
  • Hydantoins
  • Tetrazolium Salts
  • Thiazoles
  • Vinyl Compounds
  • thiazolyl blue